Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026909 · ClinicalTrials.gov registry record · NA
Intraarticular Corticosteroid Therapy in Perthes Disease.
A NA study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01026909: Clinical Trial NA study, sponsored by Seattle Children's Hospital.
NCT01026909 is a NA study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01026909, a NA study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular corticosteroid (triamcinolone hexacetonide) injection with traditional nonoperative treatment.
Primary Outcome
The Pediatric Outcomes Data Collection Instrument (PODCI) is designed to be completed by the parent/guardian of a child ten years of age or younger who has knowledge of the child's conditions. The eight scales generated from these instruments are: Upper Extremity and Physical Function Scale; Transfer and Basic Mobility Scale; Sports/Physical Functioning Scale; Pain/Comfort; Treatment Expectations Scale; Happiness Scale; Satisfaction with Symptoms Scale and Global Functioning Scale. The results
Interventions
- DRUG Aristospan 20mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-01 |
| Phase | NA |
Why NCT01026909 stopped before completion
NCT01026909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Aristospan 20mg is the first listed.
NCT01026909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01026909 about?
NCT01026909 is a clinical study titled "Intraarticular Corticosteroid Therapy in Perthes Disease.". Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular co...
What is the current status of trial NCT01026909?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2009-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01026909?
The interventions under investigation include: Aristospan 20mg (DRUG).
Who is sponsoring clinical trial NCT01026909?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01026909's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia